Sandeep Singh

Dr. Sandeep Singh


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2020 in Open Heart
Verified
Journal Article
Open access
PDF file
SSSandeep Singh
Sandeep Singh
MRMaurice W J de Ronde
Maurice W J de Ronde
MKMaayke G M Kok
Maayke G M Kok
MBMarcel Am Beijk
Marcel Am Beijk
RWRobbert J De Winter
Robbert J De Winter
SPSara-Joan Pinto-Sietsma
Sara-Joan Pinto-Sietsma
Background In this study, we discovered and validated candidate microRNA (miRNA) biomarkers for coronary artery disease (CAD). Method Candidate tissue-derived miRNAs from atherosclerotic plaque material in patients with stable coronary artery disease (SCAD) (n=14) and unstable coronary artery disease (UCAD) (n=25) were discovered by qPCR-based arrays. We validated differentially expressed miRNAs, along with seven promising CAD-associated miRNAs from the literature, in the serum of two large cohorts (n=395 and n=1000) of patients with SCAD and UCAD and subclinical atherosclerosis (SubA) and controls, respectively. Result From plaque materials (discovery phase), miR-125b-5p and miR-193b-3p were most upregulated in SCAD, whereas miR-223-3p and miR-142-3p were most upregulated in patients with UCAD. Subsequent validation in serum from patients with UCAD, SCAD, SubA and controls demonstrated significant upregulation of miR-223-3p, miR-133a-3p, miR-146-3p and miR-155-5p. The ischaemia-related miR-499-5p was also highly upregulated in patients with UCAD compared with the other groups (SCAD OR 20.63 (95% CI 11.16 to 38.15), SubA OR 96.10 (95% CI 40.13 to 230.14) and controls OR 15.73 (95% CI 7.80 to 31.72)). However, no significant difference in miR-499-5p expression was observed across SCAD, SubA and controls. MiR-122-5p was the only miRNA to be significantly upregulated in the serum of both patients with UCAD and SCAD. Conclusion In conclusion, miR-122-5p and miR-223-3p might be markers of plaque instability.

1 April 2014 in South Asian Journal of Cancer
Verified
Journal Article
Open access
PDF file
SSSandeep Singh
Sandeep Singh
SBSorabh Badaya
Sorabh Badaya
South Asian J Cancer, Official publication of MedIntel Services Pvt Ltd,India

1 October 2018 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
RAVI MEHROTRARAVI MEHROTRA
RAVI MEHROTRA
STSonam Tulsyan
Sonam Tulsyan
Showket HussainShowket Hussain
Showket Hussain
BMBalraj Mittal
Balraj Mittal
SSSundeep Singh Saluja
Sundeep Singh Saluja
GRG.K. Rath
G.K. Rath

1 October 2015 in Indian Journal of Medical and Paediatric Oncology
Verified
Journal Article
Open access
PDF file
SSSandeep Singh
Sandeep Singh
JSJyoti Priyadarshini Shrivastava
Jyoti Priyadarshini Shrivastava
ADAnkit Dwivedi
Ankit Dwivedi
Indian J Med Paediatr Oncol, Official publication of Indian Society of Medical and Paediatric Oncology

1 August 2019 in Critical Care Medicine
Verified
Journal Article
Closed access
RDRupak Desai
Rupak Desai
BHBishoy Hanna
Bishoy Hanna
SSSandeep Singh
Sandeep Singh
AOAhmed Omar
Ahmed Omar
ADAbhishek Deshmukh
Abhishek Deshmukh
RSRajesh Sachdeva
Rajesh Sachdeva
Objectives: Atrial fibrillation is frequently seen in sepsis-related hospitalizations. However, large-scale contemporary data from the United States comparing outcomes among sepsis-related hospitalizations with versus without atrial fibrillation are limited. The aim of our study was to assess the frequency of atrial fibrillation and its impact on outcomes of sepsis-related hospitalizations. Design: Retrospective cohort study. Setting: The National Inpatient Sample databases (2010–2014). Patients: Primary discharge diagnosis of sepsis with and without atrial fibrillation were identified using prior validated International Classification of Diseases, 9th Edition, Clinical Modification codes. Interventions: None. Measurements and Main Results: Overall, 5,808,166 hospitalizations with the primary diagnosis of sepsis, of which 19.4% (1,126,433) were associated with atrial fibrillation. The sepsis-atrial fibrillation cohort consisted of older (median [interquartile range] age of 79 yr [70–86 yr] vs 67 yr [53–79 yr]; p < 0.001) white (80.9% vs 68.8%; p < 0.001) male (51.1% vs 47.5%; p < 0.001) patients with an extended length of stay (median [interquartile range] 6 d [4–11 d] vs 5 d [3–9 d]; p < 0.001) and higher hospitalization charges (median [interquartile range] $44,765 [$23,234–$88,657] vs $35,737 [$18,767–$72,220]; p < 0.001) as compared with the nonatrial fibrillation cohort. The all-cause mortality rate in the sepsis-atrial fibrillation cohort was significantly higher (18.4% and 11.9%; p = 0.001) as compared with those without atrial fibrillation. Although all-cause mortality (20.4% vs 16.6%) and length of stay (median [interquartile range] 7 d [4–11 d] vs 6 d [4–10 d]) decreased between 2010 and 2014, hospitalization charges increased (median [interquartile range] $41,783 [$21,430–$84,465] vs $46,251 [$24,157–$89,995]) in the sepsis-atrial fibrillation cohort. The greatest predictors of mortality in the atrial fibrillation-sepsis cohort were African American race, female gender, advanced age, and the presence of medical comorbidities. Conclusions: The presence of atrial fibrillation among sepsis-related hospitalizations is a marker of poor prognosis and increased mortality. Although we observed rising trends in sepsis and sepsis-atrial fibrillation–related hospitalizations during the study period, the rate and odds of mortality progressively decreased.

1 April 2019 in International Journal of Cardiology
Verified
Journal Article
Closed access
RDRupak Desai
Rupak Desai
UPUpenkumar Patel
Upenkumar Patel
SSSandeep Singh
Sandeep Singh
RBRushikkumar Bhuva
Rushikkumar Bhuva
HFHee Kong Fong
Hee Kong Fong
Rajkumar DoshiRajkumar Doshi
Rajkumar Doshi